Faster Seizure Medicine Reduction May Shorten Hospital Stays

What was studied

This study looked at how quickly antiseizure medicines were reduced during hospital stays in an epilepsy monitoring unit (EMU), where video-EEG is used to record seizures for diagnosis and treatment planning. The researchers reviewed records from 639 patients admitted to one EMU at the University of Pennsylvania between 2017 and 2023.

They used computer methods to pull information from medical records and estimated each patient’s overall antiseizure medicine load during the admission. They then studied whether taper speed and medicine load were linked to length of stay and to the risk of bilateral tonic-clonic seizures, including differences between patients with and without a past history of these seizures.

What they found

Faster medicine tapering was not linked to a higher risk of bilateral tonic-clonic seizures. But the actual antiseizure medicine load during the stay was associated with that risk.

Seizures happened at different medicine levels depending on seizure history. Bilateral tonic-clonic seizures occurred at higher medicine loads in patients who already had a history of them than in patients who did not. The first seizure recorded in the EMU happened at a median of about one-third of baseline medicine load in patients with or without a past history of bilateral tonic-clonic seizures.

Longer time until the first seizure and taking more antiseizure medicines at baseline were linked with longer hospital stays. The authors report that this pattern suggests sequential medication taper may delay seizures and prolong length of stay without altering bilateral tonic-clonic seizure risk. They also suggest that, in patients without a history of bilateral tonic-clonic seizures, reducing to about 50% of baseline medicine load more quickly may produce seizures more efficiently without increased bilateral tonic-clonic seizure risk.

Limits of the evidence

This was a retrospective study from a single hospital, so it cannot prove that one taper method causes better or safer outcomes. The results may not apply to all EMUs or to all patient groups.

The study relied on medical records and estimated medicine load based on pharmacokinetic models rather than direct blood levels for every drug. The abstract does not give detailed results for all patient subgroups or all possible harms, so some uncertainty remains. The authors also say taper plans should still be individualized, especially in severe epilepsies.

For families and caregivers

For families, this study suggests that how antiseizure medicines are lowered in the EMU may affect how long a hospital stay lasts. A slower, step-by-step taper may delay getting the needed seizure recording, without a clear reduction in bilateral tonic-clonic seizure risk in this study.

At the same time, the study does not mean there is one best taper plan for everyone. A person’s seizure history, especially any past bilateral tonic-clonic seizures, still seems important when planning EMU medication changes.

What to watch next

Stronger evidence would come from studies at multiple centers that directly compare taper plans and track both seizure capture and safety outcomes.

Terms in this summary

epilepsy monitoring unit (EMU)

A hospital unit where people are watched closely with video and EEG to record seizures safely.

video-EEG

A test that records brain wave activity and video at the same time to help doctors understand seizure events.

antiseizure medication (ASM)

Medicine used to prevent or reduce seizures.

taper

To lower a medicine dose gradually over time.

bilateral tonic-clonic seizure (BTCS)

A seizure with stiffening and jerking movements that affects both sides of the body and usually causes loss of awareness.

baseline

The starting level before changes are made.

length of stay (LOS)

How long a person stays in the hospital.

retrospective study

A study that looks back at existing records instead of assigning treatments ahead of time.